Advanced systemic mastocytosis with strong expression of signaling lymphocyte activation marker family member 7 (SLAMF7) responsive to therapy with elotuzumab and lenalidomide. Issue 2 (28th January 2020)

Record Type:: Journal Article
Title:: Advanced systemic mastocytosis with strong expression of signaling lymphocyte activation marker family member 7 (SLAMF7) responsive to therapy with elotuzumab and lenalidomide. Issue 2 (28th January 2020)
Main Title:: Advanced systemic mastocytosis with strong expression of signaling lymphocyte activation marker family member 7 (SLAMF7) responsive to therapy with elotuzumab and lenalidomide
Authors:: Elmaagacli, Ahmet H.
Jehn, Christian
Shikova, Yana
Huber, Michael
Salwender, Hans
Dahmash, Farouk
Singh, Anju
Niggemann, Cornelius
Vierbuchen, Mathias
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 61:Issue 2(2020)
Journal:: Leukemia & lymphoma
Issue:: Volume 61:Issue 2(2020)
Issue Display:: Volume 61, Issue 2 (2020)
Year:: 2020
Volume:: 61
Issue:: 2
Issue Sort Value:: 2020-0061-0002-0000
Page Start:: 485
Page End:: 487
Publication Date:: 2020-01-28
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2019.1668939 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 17052.xml